Skip to main content
. 2017 May 24;4(2):109–117. doi: 10.1007/s40801-017-0109-6

Table 1.

Patient and physician assessments

Study visit Time (months) Actions/documentation Documented by
INV PAT
Admission/treatment initiation 0 Allergy history–clinical manifestations x
Allergy history–allergies in need of treatment x
Symptoms/symptomatic medication intake (during the last grass pollen season) x
Diagnostic tests x
Concomitant diseases/medication x
Documentation of date of first SLIT dose taken under medical supervision (30 min) x
QUARTIS questionnaire (Q1) x
Follow-up prescriptions (optional) 1–4 Adverse events/side effects x
Receipt of follow-up prescription x
Booking of follow-up/control appointment x
QUARTIS questionnaire (Q2) x
Post-treatment visit 5–6 (approximately) Documentation of date x x
Date of last intake x x
Treatment conduct (titration/dose) x x
Symptoms/symptomatic medication intake (during the grass pollen season) x
Patient well-being x x
Tolerability x x
Adverse events/side effects x
Date and reason for premature termination of treatment if applicable x
Continuation of treatment x
QUARTIS questionnaire (Q2) x

INV investigators, PAT patients, Q questionnaire, QUARTIS Questionnaire sur l’Allergie Respiratoire Traitée par Immunothérapie Sublinguale, SLIT sublingual immunotherapy